Summary

The global Rabies Antiserum market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Rabies antiserum is a biological product derived from animal serum used as passive immunity against the rabies virus.
The market for rabies antiserum is driven by its applications in the treatment of rabies exposure and prophylaxis. Rabies antiserum provides immediate protection against the virus while the body"s immune system responds to the rabies vaccine. As rabies remains a significant public health concern in some regions, the demand for rabies antiserum is expected to continue.
The global Rabies Antiserum market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Serum China
Lanzhou Institute of Biological Products
Wuhan Institute of Biological Products
Premium Serums
Haffkine Bio-Pharmaceutical
Bharat Serums
Segment by Type
1500IU
1000IU
400IU
Other
Segment by Application
Category II Exposure
Category III Exposure
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Rabies Antiserum sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Rabies Antiserum manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Rabies Antiserum product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Rabies Antiserum value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Rabies Antiserum Product Scope
1.2 Rabies Antiserum by Type
1.2.1 Global Rabies Antiserum Sales by Type (2021, 2025 & 2032)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Rabies Antiserum by Application
1.3.1 Global Rabies Antiserum Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Rabies Antiserum Market Estimates and Forecasts (2021-2032)
1.4.1 Global Rabies Antiserum Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Rabies Antiserum Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Rabies Antiserum Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global Rabies Antiserum Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Rabies Antiserum Historical Market Scenario by Region (2021-2026)
2.2.1 Global Rabies Antiserum Sales Market Share by Region (2021-2026)
2.2.2 Global Rabies Antiserum Revenue Market Share by Region (2021-2026)
2.3 Global Rabies Antiserum Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Rabies Antiserum Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Rabies Antiserum Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Rabies Antiserum Market Size and Prospects (2021-2032)
2.4.2 Europe Rabies Antiserum Market Size and Prospects (2021-2032)
2.4.3 China Rabies Antiserum Market Size and Prospects (2021-2032)
2.4.4 Japan Rabies Antiserum Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global Rabies Antiserum Historical Market Review by Type (2021-2026)
3.1.1 Global Rabies Antiserum Sales by Type (2021-2026)
3.1.2 Global Rabies Antiserum Revenue by Type (2021-2026)
3.1.3 Global Rabies Antiserum Average Price by Type (2021-2026)
3.2 Global Rabies Antiserum Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Rabies Antiserum Sales Forecast by Type (2027-2032)
3.2.2 Global Rabies Antiserum Revenue Forecast by Type (2027-2032)
3.2.3 Global Rabies Antiserum Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Rabies Antiserum
4 Global Market Size by Application
4.1 Global Rabies Antiserum Historical Market Review by Application (2021-2026)
4.1.1 Global Rabies Antiserum Sales by Application (2021-2026)
4.1.2 Global Rabies Antiserum Revenue by Application (2021-2026)
4.1.3 Global Rabies Antiserum Average Price by Application (2021-2026)
4.2 Global Rabies Antiserum Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Rabies Antiserum Sales Forecast by Application (2027-2032)
4.2.2 Global Rabies Antiserum Revenue Forecast by Application (2027-2032)
4.2.3 Global Rabies Antiserum Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Rabies Antiserum Applications
5 Competition Landscape by Players
5.1 Global Rabies Antiserum Sales by Player (2021-2026)
5.2 Global Top Rabies Antiserum Players by Revenue (2021-2026)
5.3 Global Rabies Antiserum Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Rabies Antiserum revenue as of 2025
5.4 Global Rabies Antiserum Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Rabies Antiserum, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Rabies Antiserum, Product Type & Application
5.7 Global Key Manufacturers of Rabies Antiserum, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Rabies Antiserum Sales by Company
6.1.1.1 North America Rabies Antiserum Sales by Company (2021-2026)
6.1.1.2 North America Rabies Antiserum Revenue by Company (2021-2026)
6.1.2 North America Rabies Antiserum Sales Breakdown by Type (2021-2026)
6.1.3 North America Rabies Antiserum Sales Breakdown by Application (2021-2026)
6.1.4 North America Rabies Antiserum Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Rabies Antiserum Sales by Company
6.2.1.1 Europe Rabies Antiserum Sales by Company (2021-2026)
6.2.1.2 Europe Rabies Antiserum Revenue by Company (2021-2026)
6.2.2 Europe Rabies Antiserum Sales Breakdown by Type (2021-2026)
6.2.3 Europe Rabies Antiserum Sales Breakdown by Application (2021-2026)
6.2.4 Europe Rabies Antiserum Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Rabies Antiserum Sales by Company
6.3.1.1 China Rabies Antiserum Sales by Company (2021-2026)
6.3.1.2 China Rabies Antiserum Revenue by Company (2021-2026)
6.3.2 China Rabies Antiserum Sales Breakdown by Type (2021-2026)
6.3.3 China Rabies Antiserum Sales Breakdown by Application (2021-2026)
6.3.4 China Rabies Antiserum Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Rabies Antiserum Sales by Company
6.4.1.1 Japan Rabies Antiserum Sales by Company (2021-2026)
6.4.1.2 Japan Rabies Antiserum Revenue by Company (2021-2026)
6.4.2 Japan Rabies Antiserum Sales Breakdown by Type (2021-2026)
6.4.3 Japan Rabies Antiserum Sales Breakdown by Application (2021-2026)
6.4.4 Japan Rabies Antiserum Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 Serum China
7.1.1 Serum China Company Information
7.1.2 Serum China Business Overview
7.1.3 Serum China Rabies Antiserum Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Serum China Rabies Antiserum Products Offered
7.1.5 Serum China Recent Development
7.2 Lanzhou Institute of Biological Products
7.2.1 Lanzhou Institute of Biological Products Company Information
7.2.2 Lanzhou Institute of Biological Products Business Overview
7.2.3 Lanzhou Institute of Biological Products Rabies Antiserum Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Lanzhou Institute of Biological Products Rabies Antiserum Products Offered
7.2.5 Lanzhou Institute of Biological Products Recent Development
7.3 Wuhan Institute of Biological Products
7.3.1 Wuhan Institute of Biological Products Company Information
7.3.2 Wuhan Institute of Biological Products Business Overview
7.3.3 Wuhan Institute of Biological Products Rabies Antiserum Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Wuhan Institute of Biological Products Rabies Antiserum Products Offered
7.3.5 Wuhan Institute of Biological Products Recent Development
7.4 Premium Serums
7.4.1 Premium Serums Company Information
7.4.2 Premium Serums Business Overview
7.4.3 Premium Serums Rabies Antiserum Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Premium Serums Rabies Antiserum Products Offered
7.4.5 Premium Serums Recent Development
7.5 Haffkine Bio-Pharmaceutical
7.5.1 Haffkine Bio-Pharmaceutical Company Information
7.5.2 Haffkine Bio-Pharmaceutical Business Overview
7.5.3 Haffkine Bio-Pharmaceutical Rabies Antiserum Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Haffkine Bio-Pharmaceutical Rabies Antiserum Products Offered
7.5.5 Haffkine Bio-Pharmaceutical Recent Development
7.6 Bharat Serums
7.6.1 Bharat Serums Company Information
7.6.2 Bharat Serums Business Overview
7.6.3 Bharat Serums Rabies Antiserum Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Bharat Serums Rabies Antiserum Products Offered
7.6.5 Bharat Serums Recent Development
8 Rabies Antiserum Manufacturing Cost Analysis
8.1 Rabies Antiserum Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Rabies Antiserum
8.4 Rabies Antiserum Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Rabies Antiserum Distributors List
9.3 Rabies Antiserum Customers
10 Rabies Antiserum Market Dynamics
10.1 Rabies Antiserum Industry Trends
10.2 Rabies Antiserum Market Drivers
10.3 Rabies Antiserum Market Challenges
10.4 Rabies Antiserum Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer